Results of ARISTOTLE, RE-LY, and ROCKET-AF trials according to subgroup.

Figshare2015-12-02 更新2026-04-29 收录

下载链接：

https://figshare.com/articles/dataset/_Results_of_ARISTOTLE_RE_LY_and_ROCKET_AF_trials_according_to_subgroup_/959149

下载链接

链接失效反馈

官方服务：

资源简介：

A: apixaban; Bid: twice daily; D: dabigatran; HR: hazard ratio; MB: major bleeding; NR: not reported; od: once daily; R: rivaroxaban; SE: systemic embolism; SSE: stroke and/or systemic embolism; TIA: transient ischemic attack; VKA: vitamin K antagonist.

创建时间：

2015-12-02